Optimization of oral chemotherapy in outpatient clinics in Spain: results from a survey of the Spanish Society of Medical Oncology (SEOM)

• A. Santaballa ^[4] ; J. De Castro ^[1] ; J. Maurel ^[5] ; M. Lázaro ^[6] ; R. Vera ^[2] ; E. Alba ^[3]
  1. [1] Hospital Universitario La Paz

     Hospital Universitario La Paz

     Madrid, España

     
  2. [2] Gobierno de Navarra

     Gobierno de Navarra

     Pamplona, España

     
  3. [3] Hospital Regional Universitario de Málaga

     Hospital Regional Universitario de Málaga

     Málaga, España

     
  4. [4] Hospital Universitari i Politècnic La Fe, Valencia
  5. [5] Hospital Clínic Universitari de Barcelona
  6. [6] Hospital Universitario Álvaro Cunqueiro, Vigo

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 21, Nº. 4, 2019, págs. 534-538
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Purpose To determine the current management of oral and intravenous chemotherapy (OC and IVC) in outpatient clinics of Oncology Departments in Spain to detect opportunities for improvement.

    Materials and methods The Spanish Society of Medical Oncology designed a questionnaire specifically for Heads of Oncology Department: 142 were invited and 52 responded.

    Results In most centers, the waiting time (69.7%) and time at the outpatient clinic (84.8%) was shorter for patients receiving OC compared to those receiving IVC. The time spent at the outpatient clinic by the patients having OC was approximately 30 min (88.5%). In addition, the time expended by the oncologist with each patient was shorter when they were treated with OC in 21.2% of cases.

    Conclusions Patients’ waiting times and individual dedication of oncologists might be reduced by administering OC, and general management might be improved. This should be considered when planning therapies if OC is an option.